Amryt Pharma Says European Commission Oks Filsuvez For Dystrophic And Junctional EB

RTTNews | 1140 일 전
Amryt Pharma Says European Commission Oks Filsuvez For Dystrophic And Junctional EB

(RTTNews) - Biopharmaceutical company Amryt Pharma plc (AMYT) announced the European Commission (EC) approval of Filsuvez in the European Union (EU) for the treatment of partial thickness wounds associated with dystrophic and junctional Epidermolysis Bullosa (EB) in patients 6 months and older.

EB is a rare and distressing genetic skin disorder affecting young children and adults for which, until now, there has been no approved treatment in any market.

The centralized marketing authorization will be valid in all EU Member States as well as in Iceland, Liechtenstein, and Norway. The authorization of Filsuvez in the EU provides a regulatory core dossier which may form the basis for future regulatory submissions in LATAM and the Middle East.

The EC approval of Filsuvez is supported by Phase 3 data from the EASE trial which was the largest ever global trial conducted in patients with EB, performed across 58 sites in 28 countries.

read more
Amryt Pharma To Submit Formal Dispute Resolution Request For Oleogel-S10 NDA

Amryt Pharma To Submit Formal Dispute Resolution Request For Oleogel-S10 NDA

Biopharmaceutical company Amryt Pharma plc (AMYT) announced Friday that the company plans to submit a Formal Dispute Resolution Request (FDRR) for the company's New Drug Application (NDA) for Oleogel-S10 (Filsuvez), for the treatment of the cutaneous manifestations of Dystrophic and Junctional Epidermolysis Bullosa (EB).
RTTNews | 1139 일 전
Sensex, Nifty Open Lower On Tariff Concerns

Sensex, Nifty Open Lower On Tariff Concerns

Indian shares opened a tad lower on Thursday after U.S. President Donald Trump signed an executive order imposing an additional 25 percent tariff on India as a "penalty" in response to its continued purchase of Russian oil.
RTTNews | 41 분 전
Australian Market Extends Early Losses In Mid-market

Australian Market Extends Early Losses In Mid-market

The Australian market is extending early losses in mid-market moves on Thursday, snapping a three session winning streak, despite the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying below the 8,850 level, with weakness in iron ore miners and energy stocks.
RTTNews | 1 시간 38 분 전
Asian Markets Trade Mostly Higher

Asian Markets Trade Mostly Higher

Asian stock markets are trading mostly higher on Thursday, despite the broadly positive cues from Wall Street overnight, after U.S. President Donald Trump said the U.S. was closing in on the trade deal with China. Traders also remain optimistic about the US Fed cutting interest rates as early as September based on the recent economic data from the U.S.
RTTNews | 2 시간 5 분 전
Thai Stock Market May See Continued Support On Thursday

Thai Stock Market May See Continued Support On Thursday

The Thai stock market has moved higher in three straight sessions, gathering more than 45 points or 3.9 percent along the way. The Stock Exchange of Thailand now sits just beneath the 1,265-point plateau and it's expected to extend its gains again on Thursday.
RTTNews | 3 시간 8 분 전
Australia June Trade Surplus A$5.365 Billion

Australia June Trade Surplus A$5.365 Billion

Australia posted a seasonally adjusted merchandise trade surplus of A$5.365 billion in June, the Australian Bureau of Statistics said on Thursday.
RTTNews | 3 시간 20 분 전
Australia Building Approvals Jump 11.9% In June

Australia Building Approvals Jump 11.9% In June

The total number of building approvals issued in Australia in June was up a seasonally adjusted 11.9 percent on month, the Australian Bureau of Statistics said on Thursday - coming in at 17,076.
RTTNews | 3 시간 29 분 전